Alcoholic Hepatitis Clinical Trials

13 recruitingLast updated: May 29, 2026

There are 13 actively recruiting alcoholic hepatitis clinical trials across 6 countries. Studies span Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3. Top locations include Paris, France, Cleveland, Ohio, United States, Baltimore, Maryland, United States. Updated daily from ClinicalTrials.gov.


Alcoholic Hepatitis Trials at a Glance

13 actively recruiting trials for alcoholic hepatitis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Paris, Cleveland, and Baltimore. Lead sponsors running alcoholic hepatitis studies include The Cleveland Clinic, Bioaraba Health Research Institute, and Assistance Publique - Hôpitaux de Paris.

Browse alcoholic hepatitis trials by phase

Treatments under study

About Alcoholic Hepatitis Clinical Trials

Looking for clinical trials for Alcoholic Hepatitis? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Alcoholic Hepatitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Alcoholic Hepatitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease

Alcoholic Liver DiseaseAlcoholic CirrhosisSevere alcoholic hepatitis
University Hospital, Lille447 enrolled9 locationsNCT04106518
Recruiting

Intra-Hepatic Microbiota in Alcoholic Hepatitis

Alcoholic HepatitisCirrhosisAlcoholic Liver Disease
Hospices Civils de Lyon50 enrolled1 locationNCT06307964
Recruiting
Not Applicable

Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)

Alcoholic Hepatitis
Bioaraba Health Research Institute390 enrolled1 locationNCT05294744
Recruiting

Integrative Epidemiology of Prognosis in Patients With Acute Alcoholic Hepatitis at AP-HP

Acute Alcoholic Hepatitis
Assistance Publique - Hôpitaux de Paris1,400 enrolled1 locationNCT07262515
Recruiting

Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis

Alcoholic Hepatitis
The Cleveland Clinic30 enrolled1 locationNCT04088370
Recruiting
Early Phase 1

HA35 Moderate Alcoholic Hepatitis (AH) Study

Alcoholic Hepatitis
The Cleveland Clinic54 enrolled1 locationNCT05018481
Recruiting

Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease

Alcoholic HepatitisAlcohol-related Liver Disease
HepQuant, LLC40 enrolled1 locationNCT07060547
Recruiting
Not Applicable

Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

Alcoholic HepatitisAlcohol Use Disorder
Johns Hopkins University200 enrolled1 locationNCT03845205
Recruiting
Not Applicable

Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients

CorticosteroidsSevere Acute Alcoholic HepatitisAlcohol+1 more
Centre Hospitalier Universitaire, Amiens200 enrolled1 locationNCT06159244
Recruiting
Phase 3

Short Course Steroids in Alcohol Associated Hepatitis

Alcoholic Hepatitis
Asian Institute of Gastroenterology, India146 enrolled2 locationsNCT06919458
Recruiting
Not Applicable

Recompensation in Alcohol Related Hepatitis

Alcoholic Hepatitis (AH)
Nina Kimer160 enrolled1 locationNCT06740318
Recruiting
Phase 1Phase 2

Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis

Alcoholic Hepatitis
Prasun Kumar Jalal50 enrolled1 locationNCT05006430
Recruiting

When drugs don't work: A psychological intervention for Alcohol Related Liver Disease.

Alcoholic HepatitisAlcohol Use Disorder
Metro South Health35 enrolled1 locationACTRN12619000710123